Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of Effective Dose 90 of Remimazolam That Can Maintain Loos of Consciousness From Sedation With Remimazolam in Adult Patients

NCT05379777 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT05379777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05379777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of Effective Dose 90 of Remimazolam That Can Maintain Loos of Consciousness From Sedation With Remimazolam in Adult Patients
Lead sponsor
Asan Medical Center
Phase
Phase 4
Overall status
Completed
Start date
May 11, 2022
Completion date
August 24, 2022
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, spinal, orthopedic procedures, remimazolam, sedatives